QRGANIZATIONAL STRUCTURE
研发管线
肿瘤模型
美迪西已建立将近300种肿瘤评价模型，同时我们为创新疗法赋能，全面布局肿瘤免疫疗法的评价和研究，已完成CAR-T，TCR-T, CAR-NK, 溶瘤病毒, 抗体（单抗，双抗，多抗等），siRNA, AAV等免疫疗法的模型建立及药效评价。
肿瘤模型
美迪西已建立将近300种肿瘤评价模型，同时我们为创新疗法赋能，全面布局肿瘤免疫疗法的评价和研究，已完成CAR-T，TCR-T, CAR-NK, 溶瘤病毒, 抗体（单抗，双抗，多抗等），siRNA, AAV等免疫疗法的模型建立及药效评价。
肿瘤模型
美迪西已建立将近300种肿瘤评价模型，同时我们为创新疗法赋能，全面布局肿瘤免疫疗法的评价和研究，已完成CAR-T，TCR-T, CAR-NK, 溶瘤病毒, 抗体（单抗，双抗，多抗等），siRNA, AAV等免疫疗法的模型建立及药效评价。
肿瘤模型
美迪西已建立将近300种肿瘤评价模型，同时我们为创新疗法赋能，全面布局肿瘤免疫疗法的评价和研究，已完成CAR-T，TCR-T, CAR-NK, 溶瘤病毒, 抗体（单抗，双抗，多抗等），siRNA, AAV等免疫疗法的模型建立及药效评价。
肿瘤模型
美迪西已建立将近300种肿瘤评价模型，同时我们为创新疗法赋能，全面布局肿瘤免疫疗法的评价和研究，已完成CAR-T，TCR-T, CAR-NK, 溶瘤病毒, 抗体（单抗，双抗，多抗等），siRNA, AAV等免疫疗法的模型建立及药效评价。
产品介绍-临床招募-Clinical recruitment
Clinical recruitment
Dongfang Baitai truly take the patient's needs as the starting point. We are committed to finding the best ways to improve, control and treat disease. Through clinical trials and studies, Dongfang Baitai provides patients with more diverse, more effective and safer drug choices. Now recruit suitable patients who meet the criteria to participate in clinical trials.Recruitment information is as follows:
For more information, please refer to the Drug Clinical Trial Registration and Information Publicity platform.
Name of Drug
Registration Number
Indications
Stage of trial
JY028 injection
CTR20171267
Neovascular (wet) age-related macular degeneration
Phase II clinical trial
JY025 injection
CTR20182451
Advanced solid tumor
Phase I clinical trial
JY09 injection
CTR20192166
Type 2 diabetes
Phase II clinical trial
JY025 injection
CTR20220059
Advanced non-small cell lung cancer
Phase I b clinical trial
JY025 injection
CTR20211128
Locally advanced or metastatic non-squamous non-small cell lung cancer
Phase II clinical trial
JY028 injection
CTR20201647
For metastatic colorectal cancer, advanced, metastatic or recurrent non-small cell lung cancer
Phase I clinical trial
JY028 injection
CTR20192184
Metastatic colorectal cancer; Non-small cell lung cancer
Phase I clinical trial
JY026 injection
CTR20192155
Rheumatoid arthritis; Ankylosing spondylitis
Phase I clinical trial
JY09 injection
CTR20180008
Type 2 diabetes
Phase I clinical trial
JY09 injection
CTR20160613
Type 2 diabetes
Phase II clinical trial
Follow us
Follow the official WeChat official account
Or search "Oriental Baitai"
More exciting waiting for you!
Address: No. 2, Rongjing East Street, Beijing Economic and Technological Development Zone
Tel.: 010-51571019
Email: ebt@east-bt.com
Copyright 2021 Beijing Dongfang Baitai Biotechnology Co., Ltd SEO 京ICP备********号
